These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21844535)

  • 1. ACP Journal Club. Review: angiotensin-receptor blockers do not increase adverse cardiovascular outcomes.
    Halim SA; Newby LK
    Ann Intern Med; 2011 Aug; 155(4):JC2-2. PubMed ID: 21844535
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Angiotensin-receptor blockers increase risk for cancer but not cancer-related death.
    Vavalle JP; Newby LK
    Ann Intern Med; 2010 Dec; 153(12):JC6-8. PubMed ID: 21173409
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD.
    Hsu CY
    Ann Intern Med; 2010 Nov; 153(10):JC5-3. PubMed ID: 21079210
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes.
    Melnikow J
    Ann Intern Med; 2010 Mar; 152(6):JC3-4. PubMed ID: 20231558
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Review: Oral drugs for gestational diabetes do not increase adverse maternal and neonatal outcomes more than insulin.
    Feig D
    Ann Intern Med; 2009 Apr; 150(8):JC4-9. PubMed ID: 19391223
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users.
    Brophy JM
    Ann Intern Med; 2011 Oct; 155(8):JC4-5. PubMed ID: 22007064
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Review: Fibrates reduce risk for cardiovascular outcomes.
    Santos RD
    Ann Intern Med; 2010 Nov; 153(10):JC5-11. PubMed ID: 21079206
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Review: Preoperative brain natriuretic peptide level is an independent predictor of adverse cardiovascular events after noncardiac surgery.
    Kaw R; Cai O
    Ann Intern Med; 2010 Mar; 152(6):JC3-12. PubMed ID: 20231554
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club: review: dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes.
    Chatterjee S; Chatterjee S
    Ann Intern Med; 2013 Apr; 158(8):JC8. PubMed ID: 23588773
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events.
    Krebs P; Sherman SE
    Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes.
    Deedwania P
    Ann Intern Med; 2011 Aug; 155(4):JC2-12. PubMed ID: 21844545
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure.
    Singh V
    Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Review: oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD.
    Ram FS
    Ann Intern Med; 2011 Sep; 155(6):JC3-2. PubMed ID: 21930839
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: biologic agents increase short-term risk for some adverse events in conditions other than HIV or AIDS.
    Schattner A
    Ann Intern Med; 2012 May; 156(10):JC5-9. PubMed ID: 22586027
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients.
    Basu A
    Ann Intern Med; 2010 Feb; 152(4):JC-213. PubMed ID: 20157125
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. Review: high-calorie supplements increase weight in persons with dementia and feeding problems; no evidence exists for other outcomes.
    Lim LS
    Ann Intern Med; 2011 Aug; 155(4):JC2-5. PubMed ID: 21844538
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Perioperative beta-blockers provide no clear benefit in patients having noncardiac surgery.
    McColl RJ; Dixon E
    Ann Intern Med; 2009 Mar; 150(6):JC3-4. PubMed ID: 19306485
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Increased frequency of hemodialysis reduced adverse clinical outcomes.
    Nesrallah GE
    Ann Intern Med; 2011 Apr; 154(8):JC4-6. PubMed ID: 21502644
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease.
    Stanbrook MB
    Ann Intern Med; 2009 Jan; 150(2):JC1-6, JC1-7. PubMed ID: 19172711
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Antidepressants were associated with increased risk for adverse outcomes in depressed elders.
    Ito K
    Ann Intern Med; 2012 Feb; 156(4):JC2-13. PubMed ID: 22351739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.